Please assess the completion status of the following clinical trial:

Trial Title: IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA I, II,III;~* BMI \> 35 kg/m2,~* Age between 18-70,~* Fluent in English,~* Patients undergoing laparoscopic gastric bypass,~* EKG within 3 months.~Exclusion Criteria:~* History of allergy to local anesthetics,~* History of chronic opioid use,~* Pregnant patients,~* History of EKG abnormalities.~Dropout: Conversion to open, patient or surgeon request.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: ACTIVE_COMPARATOR): Lidocaine infusion
- Placebo (Type: PLACEBO_COMPARATOR): Placebo Normal Saline Infusion

Based on this trial design, predict the completion outcome and termination type (if applicable).